Page 1692 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

60. Burns K, Johnson B, Iacono A. Diagnostic properties of trans- 79. Ozal E. Preoperative methylene blue administration in patients
bronchial biopsy in lung transplant recipients who require at high risk for vasoplegic syndrome during cardiac surgery.
mechanical ventilation. J Heart Lung Transplant. 2003;22(3): Ann Thorac Surg. 2005;79(5):1615-1619.
267-275. 80. Cywinski J, Mascha E, You J, et al. Central venous pressure dur-
61. Weill D, McGiffin D, Zorn GJ, et al. The utility of open lung ing the post-anhepatic phase is not associated with early post-
biopsy following lung transplantation. J Heart Lung Transplant. operative outcomes following orthotopic liver transplantation.
2000;19:852. Minerva Anestesiol. 2010;76:795-804.
62. Chaparro C, Maurer JR, Chamberlain DW, Todd TR. Role of 81. Krowka M, Plevak D, Findlay J, Rosen C, Wiesner R, Krom R.
open lung biopsy for diagnosis in lung transplant recipients: Pulmonary hemodynamics and perioperative cardiopulmonary-
ten-year experience. Ann Thorac Surg. 1995;59:928. related mortality in patients with portopulmonary hypertension
63. Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic undergoing liver transplantation. Liver Transpl. 2000;6(4):443-
value of Child-Turcotte criteria in medically treated cirrhosis. 450.
Hepatology. 1984;4(3):430-435. 82. Lowell J, Shaw Jr B. Critical care of liver transplant recipients.
64. Stravitz R. Critical management decisions in patients with acute In: Maddrey WC, Schiff ER, Sorrell MF, eds. Transplantation
liver failure. Chest. 2008;134:1092-1102. of the Liver. Philadephia, PA: Lippincott, Williams & Wilkins;
65. Freeman R. Model for end-stage liver diseae (MELD) for 2001:385.
liver allocation: a 5-year score card. Hepatology. 2008;47(3): 83. McGilvray I, Greig P. Critical care of the liver transplant patient:
1052-1057. an update. Curr Opin Crit Care. 2002;8:178.
84. Mandell M, Lezotte D, Kam I, Zamudio S. Reduced use of inten-
66. Wiesner R, Edwards E, Freeman R. Model for end-stage liver
diseae (MELD) and allocation of donor livers. Gastroenterology. sive care after liver transplantation: influence of early extuba-
2003;124(1):91-96. tion. Liver Transpl. 2002;8(8):676-681.
67. O’Grady J, Alexander G, Hayllar K, Williams R. Early indica- 85. Jain A, Kashyap R, Marsh W, Rohal S, Khanna A, Fung J.
tors of prognosis in fulminant hepatic failure. Gastroenterology. Reasons for long-term use of steroid in primary adult liver
1989;97(4):439. transplantation under tacrolimus. Transplantation. 2001;71(8):
1102-1106.
68. Moon DB, Lee SG. Liver transplantation. Gut Liver. 2009;3(3):
145-165. 86. Sgourakis G, Radtke A, Fouzas I, et al. Corticosteroid-free
immunosuppression in liver transplantation: a meta-analysis
69. Olthoff KM, Merion RM, Ghobrial RM, et al. Outcomes of and meta-regression of outcomes. Transpl Int. 2009;22(9):
385 adult-to-adult living donor liver transplant recipients: a 892-905.
report from the A2ALL Consortium. Ann Surg. 2005;242(3): 87. Vivarelli M, Burra P, La Barba G, et al. Influence of steroids on
314-323. HCV recurrence after liver transplantation: a prospective study.
70. Said A, Lucey MR. Liver transplantation: an update 2008. Curr J Hepatol. 2007;47(6):793-798.
Opin Gastroenterol. 2008;24(3):339-345. 88. McAlister V, Haddad E, Renouf E, Malthaner R, Kjaer M,
71. Freise C, Gillespie B, Koffron A, et al. Recipient morbidity Gluud L. Cyclosporin versus tacrolimus as primary immuno-
after living and deceased donor liver transplantation: findings suppressant after liver transplantation: a meta-analysis. Am J
from the A2ALL Retrospective Cohort Study. Am J Transplant. Transplant. 2006;6(7):1578-1585.
2008;8(12):2569-2579.
89. Haddad E, McAlister V, Renouf E, Malthaner R, Kjaer M, Gluud
72. Mor E, Klintmalm G, Gonwa T, et al. The use of marginal L. Cyclosporin versus tacrolimus for liver transplanted patients.
donors for liver transplantation: a retrospective study of 365 Cochrane Database Syst Rev. 2006;(4):CD005161.
liver donors. Transplantation. 1992;53(2):383-386.
90. Neuberger J, Mamelok R, Neuhaus P. Delayed introduction of
73. Furukawa H, Todo S, Imventarza O, et al. Effect of cold isch- reduced-dose tacrolimus and renal function in liver transplan-
emia time on the early otucome of human hepatic allografts tation: the ‘ReSpECT’ study. Am J Transplant. 2009;9:327.
preserved with UW solution. Transplantation. 1991;51(5): 91. Nakagawa M, Sakamoto N, Enomoto N, et al. Specific inhibition
1000-1004. of hepatitis C virus replication by cyclosporin A. Biochemical
74. Reich D, Munoz S, Rothstein K, et al. Controlled non-heart Biophys Res Commun. 2004;313(1):42-47.
beating donor liver transplantation: a successful single center 92. Vivarelli M, Dazzi A, Cucchetti A, et al. Sirolimus in liver
experience, with topic update. Transplantation. 2000;70(8): transplantation recipients: a large single-center experience.
1159-1166. Transplant Proc. 2010;42:2579-2584.
75. Brown R. A survey of liver transplantation from living adult 93. Fernández-Merino J, Nuño-Garza J, López-Hervás P, López-
donors in the United States. N Engl J Med. 2003;348:818. Buenadicha A, Quijano-Collazo Y, Vicente-López E. Influence
76. Trotter J. Adult-to-adult transplantation of the right hepatic of ischemia and surgery times on development of primary
lobe from a living donor. N Engl J Med. 2002;346(1074). dysfunction liver transplant in patients. Transplant Proc.
77. de Boer M, Molenaar I, Hendriks H, Slooff M, Porte R. 2003;35:1439.
Minimizing blood loss in liver transplantation: progress through 94. Bennett-Guerrero E, Feierman D, Barclay G, et al. Preoperative
research and techniques. Dig Surg. 2005;22(4):265-275. and intraoperative predictors of postoperative morbidity, poor
78. Massicotte L, Lenis S, Thibeault L, et al. Effect of low central graft function, and early rejection in 190 patients undergoing
venous pressure and phlebotomy on blood product transfu- liver transplantation. Arch Surg. 2001;136:1177.
sion requirements during liver transplantation. Liver Transpl. 95. Pokorny H, Gruenberger T, Soliman T, Rockenschaub S, Längle
2006;12:117-123. F, Steininger R. Organ survival after primary dysfunction of

Section10-O-Ref.indd 3 1/21/2015 11:30:09 AM